title: The lipocalin-type prostaglandin D2 synthase knockout mouse model of insulin resistance and obesity demonstrates early hypothalamic-pituitary-adrenal axis hyperactivity.
abstract: Obesity and diabetes are closely associated with hyperactivation of the hypothalamic-pituitary-adrenal (HPA) axis. In this study, the diet-induced obese C57BL/6 mouse was used to test the hypothesis that chronically elevated metabolic parameters associated with the development of obesity such as cholesterol and glucose can aggravate basal HPA axis activity. Because the lipocalin-type prostaglandin D(2) synthase (L-PGDS) knockout (KO) mouse is a model of accelerated insulin resistance, glucose intolerance, and obesity, it was further hypothesized that HPA activity would be greater in this model. Starting at 8 weeks of age, the L-PGDS KO and C57BL/6 mice were maintained on a low-fat or high-fat diet. After 20 or 37 weeks, fasting metabolic parameters and basal HPA axis hormones were measured and compared between genotypes. Correlation analyses were performed to identify associations between obesity-related chronic metabolic changes and changes in the basal activity of the HPA axis. Our results have identified strong positive correlations between total cholesterol, LDL-cholesterol, glucose, and HPA axis hormones that increase with age in the C57BL/6 mice. These data confirm that obesity-related elevations in cholesterol and glucose can heighten basal HPA activity. Additionally, the L-PGDS KO mice show early elevations in HPA activity with no age-related changes relative to the C57BL/6 mice.
authors.affiliation: Biomedical Research Core, Winthrop University Hospital, 222 Station Plaza North, Suite 505-B, Mineola, New York 11501, USA.
authors.forename: Jodi F
authors.initials: JF
authors.lastname: Evans
authors.forename: Shahidul
authors.initials: S
authors.lastname: Islam
authors.forename: Yoshihiro
authors.initials: Y
authors.lastname: Urade
authors.forename: Naomi
authors.initials: N
authors.lastname: Eguchi
authors.forename: Louis
authors.initials: L
authors.lastname: Ragolia
mesh_terms: D000324:Adrenocorticotropic Hormone / Q000097:blood; D000818:Animals; D003345:Corticosterone / Q000097:blood; D005838:Genotype; D006937:Hypercholesterolemia / Q000235:genetics / Q000378:metabolism; D006943:Hyperglycemia / Q000235:genetics / Q000378:metabolism; D007030:Hypothalamo-Hypophyseal System / Q000378:metabolism*; D007333:Insulin Resistance / Q000235:genetics / Q000502:physiology*; D019746:Intramolecular Oxidoreductases / Q000235:genetics / Q000378:metabolism*; D020738:Leptin / Q000097:blood; D054834:Lipocalins / Q000235:genetics / Q000378:metabolism*; D024821:Metabolic Syndrome / Q000235:genetics / Q000378:metabolism; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D009765:Obesity / Q000235:genetics / Q000378:metabolism*; D010913:Pituitary-Adrenal System / Q000378:metabolism*
chemical_list: D020738:Leptin; D054834:Lipocalins; D000324:Adrenocorticotropic Hormone; D019746:Intramolecular Oxidoreductases; C022466:prostaglandin R2 D-isomerase; D003345:Corticosterone